Follow-up evaluation and management of anemia in inflammatory bowel disease: A study by the Italian Group for Inflammatory Bowel Diseases (IG-IBD).
Gaetano BergamaschiFabiana CastiglioneRenata D'IncàMarco AstegianoWalter FriesMonica MillaCarolina CiacciFernando RizzelloSimone SaibeniRachele CiccocioppoAmbrogio OrlandoFabrizio BossaMariabeatrice PrincipiPiero VerniaChiara RicciMaria L ScribanoGiorgia BodiniDario MazzuccoGabrio BassottiGabriele RieglerAndrea BudaMatteo NeriFlavio CaprioliFabio MonicaAldo MancaErica VillaGionata FiorinoNicola AronicoMarco V LentiCaterina MengoliAnna TestaMaurizio VecchiCatherine KlersyAntonio Di Sabatinonull nullPublished in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver (2024)
In anemic patients with IBD, anemia represents a long-lasting problem, in most cases persisting for up to 24 weeks, with high relapse rate and a negative impact on fatigue and QoL.